By Ryan Lopez, Director, Nucleus Product Management & Marketing In January 2022, Cochlear received FDA approval to treat patients with single-sided deafness (SSD) with the Cochlear™ Nucleus® System. This approval […]
By Ryan Lopez, Director of Nucleus® Product Management & Marketing With more than two decades of reporting on reliability, cochlear implants have set the bar high, and the data and […]
By Ryan Lopez, Director, Nucleus® Product Management & Marketing at Cochlear Americas For 20 years, cochlear implants have been indicated in children no younger than 12 months of age. Earlier […]
By Ryan Lopez, Director, Nucleus® Product Management & Marketing at Cochlear Americas Quality products start with Cochlear’s commitment to putting recipients first and expanding access to information to reinforce transparency. […]
Welcome to the future of hearing. The Nucleus 7 Sound Processor is the first Made for iPhone sound processor.1 This gives recipients access to connect with their technology as well […]
End of content
No more pages to load
